14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Cardiovascular Stroke in 7 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, GJ | 5 |
| Hsu, A | 4 |
| Pfeiffer, AW | 1 |
| Nithipatikom, K | 5 |
| Alánová, P | 1 |
| Husková, Z | 1 |
| Kopkan, L | 1 |
| Sporková, A | 1 |
| Jíchová, Š | 1 |
| Neckář, J | 1 |
| Imig, JD | 1 |
| Klevstig, M | 1 |
| Kolář, F | 1 |
| Rami Reddy, N | 1 |
| Falck, JR | 5 |
| Sadowski, J | 1 |
| Nishiyama, A | 1 |
| Kramer, HJ | 1 |
| Melenovský, V | 1 |
| Červenková, L | 1 |
| Kujal, P | 1 |
| Vernerová, Z | 1 |
| Červenka, L | 1 |
| Motoki, A | 1 |
| Merkel, MJ | 1 |
| Packwood, WH | 1 |
| Cao, Z | 1 |
| Liu, L | 1 |
| Iliff, J | 1 |
| Alkayed, NJ | 1 |
| Van Winkle, DM | 1 |
| Baker, JE | 1 |
| Wu, HE | 1 |
| Gross, ER | 1 |
| Gauthier, KM | 1 |
| Moore, J | 1 |
| Hammock, BD | 1 |
| Campbell, WB | 1 |
7 other studies available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Cell Line; Heart; Hemodynamics; Imines; Male; Mitochondrial Me | 2013 |
Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
Topics: 8,11,14-Eicosatrienoic Acid; Administration, Oral; Animals; Blood Pressure; Blood Pressure Monitorin | 2015 |
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Disease Models, Animal; Enzyme Inhibitors; Epoxide | 2008 |
Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.
Topics: 8,11,14-Eicosatrienoic Acid; Analgesics, Opioid; Animals; Disease Models, Animal; GTP-Binding Protei | 2010 |
Factors mediating remote preconditioning of trauma in the rat heart: central role of the cytochrome p450 epoxygenase pathway in mediating infarct size reduction.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Capsaicin; Cytochrome P-450 Enzyme System; Hemodynamics; Ische | 2013 |
Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.
Topics: 8,11,14-Eicosatrienoic Acid; Adenosine Triphosphate; Animals; Male; Myocardial Infarction; Potassium | 2007 |
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Blood Pressure; Cardiovascular Agents; Coronary Ci | 2008 |